76 related articles for article (PubMed ID: 11701697)
1. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.
Pal T; Vogl FD; Chappuis PO; Tsang R; Brierley J; Renard H; Sanders K; Kantemiroff T; Bagha S; Goldgar DE; Narod SA; Foulkes WD
J Clin Endocrinol Metab; 2001 Nov; 86(11):5307-12. PubMed ID: 11701697
[TBL] [Abstract][Full Text] [Related]
2. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases.
Li Z; Zhang H; Yan Y; Li X; Jia M; Zhou H; Lu X
Front Endocrinol (Lausanne); 2023; 14():1200855. PubMed ID: 37780622
[TBL] [Abstract][Full Text] [Related]
4. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
Wang Z; Luo J; Zhang Y; Xun P; Chen Z
PLoS One; 2022; 17(7):e0271038. PubMed ID: 35901016
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to hereditary non-medullary thyroid cancer.
Kamani T; Charkhchi P; Zahedi A; Akbari MR
Hered Cancer Clin Pract; 2022 Mar; 20(1):9. PubMed ID: 35255942
[TBL] [Abstract][Full Text] [Related]
6. Germ-line mutations in
Zhao Y; Yu T; Sun J; Wang F; Cheng C; He S; Chen L; Xie D; Fu L; Guan X; Yan A; Li Y; Miao G; Zhu X
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326253
[TBL] [Abstract][Full Text] [Related]
7. Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience.
Spinelli C; Piccolotti I; Bertocchini A; Morganti R; Materazzi G; Tonacchera M; Strambi S
World J Surg; 2021 Aug; 45(8):2473-2479. PubMed ID: 33891138
[TBL] [Abstract][Full Text] [Related]
8. Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer.
Fujita S; Masago K
Sci Rep; 2021 Feb; 11(1):3597. PubMed ID: 33574476
[TBL] [Abstract][Full Text] [Related]
9. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.
Cameselle-Teijeiro JM; Mete O; Asa SL; LiVolsi V
Endocr Pathol; 2021 Mar; 32(1):77-101. PubMed ID: 33495912
[TBL] [Abstract][Full Text] [Related]
10. FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1.
Morillo-Bernal J; Fernández LP; Santisteban P
Endocr Relat Cancer; 2020 Mar; 27(3):137-151. PubMed ID: 31846430
[TBL] [Abstract][Full Text] [Related]
11. Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer.
Hińcza K; Kowalik A; Kowalska A
Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31247975
[TBL] [Abstract][Full Text] [Related]
12. Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis.
de Melo TG; da Assumpção LVM; Zantut-Wittmann DE
Int J Endocrinol; 2018; 2018():2089471. PubMed ID: 30224918
[TBL] [Abstract][Full Text] [Related]
13. Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
Lee CR; Park S; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
Ann Surg Treat Res; 2017 Mar; 92(3):129-135. PubMed ID: 28289666
[TBL] [Abstract][Full Text] [Related]
14. Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT.
Bullock M; Lim G; Li C; Choi IH; Kochhar S; Liddle C; Zhang L; Clifton-Bligh RJ
Oncotarget; 2016 Dec; 7(52):85948-85962. PubMed ID: 27852061
[TBL] [Abstract][Full Text] [Related]
15. The impact of family history on non-medullary thyroid cancer.
Nixon IJ; Suárez C; Simo R; Sanabria A; Angelos P; Rinaldo A; Rodrigo JP; Kowalski LP; Hartl DM; Hinni ML; Shah JP; Ferlito A
Eur J Surg Oncol; 2016 Oct; 42(10):1455-63. PubMed ID: 27561845
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma.
Jiwang L; Zhendong L; Shuchun L; Bo H; Yanguo L
Acta Otorhinolaryngol Ital; 2015 Oct; 35(4):234-42. PubMed ID: 26824209
[TBL] [Abstract][Full Text] [Related]
17. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract][Full Text] [Related]
18. No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.
Becker C; Jick SS; Meier CR; Bodmer M
BMC Cancer; 2015 Oct; 15():719. PubMed ID: 26475035
[TBL] [Abstract][Full Text] [Related]
19. Controversies in familial thyroid cancer 2014.
Clark OH
Ulus Cerrahi Derg; 2014; 30(2):62-6. PubMed ID: 25931896
[TBL] [Abstract][Full Text] [Related]
20. Single-center study of familial papillary thyroid cancer in China: surgical considerations.
Lei S; Wang D; Ge J; Liu H; Zhao D; Li G; Ding Z
World J Surg Oncol; 2015 Mar; 13():115. PubMed ID: 25889362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
